Glaukos Corp (GKOS)

Exchange
NYSE
Symbol
GKOS
Sector
Life Sciences
Industry
Surgical & Medical Instruments & Apparatus
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, is focused on developing new therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. The company is headquartered in San Clemente, California.
Country
USA

Stock price

At close: February 3, 2025

  • Open
    154.62
  • High
    158.89
  • Low
    153.80
  • Close
    156.08
  • Volume
    546,847

Financial ratios

Dec 31, 2023